<i>TERT</i> Promoter Mutation and Extent of Thyroidectomy in Patients with 1–4 cm Intrathyroidal Papillary Carcinoma
There are concerns regarding overtreatment in papillary thyroid carcinoma (PTC). <i>BRAF V600E</i> and <i>TERT</i> promoter mutations play important roles in the development of PTC. However, initial surgical approaches for PTC based on genetic characteristics remain unclear....
Main Authors: | Aya Ebina, Yuki Togashi, Satoko Baba, Yukiko Sato, Seiji Sakata, Masashi Ishikawa, Hiroki Mitani, Kengo Takeuchi, Iwao Sugitani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2115 |
Similar Items
-
Prospective Analysis of <i>TERT</i> Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution
by: Yun-Suk Choi, et al.
Published: (2021-05-01) -
<i>TERT</i> Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma
by: Pauline Blateau, et al.
Published: (2020-08-01) -
<i>TERT</i> Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients
by: Jun Park, et al.
Published: (2021-02-01) -
<i>TERT</i> Promoter Mutations Increase Sense and Antisense Transcription from the <i>TERT</i> Promoter
by: François Hafezi, et al.
Published: (2021-11-01) -
Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for <i>TERT</i> Promoter Mutations
by: Sama Alohali, et al.
Published: (2023-01-01)